According to Elite Pharmaceuticals latest financial reports the total liabilities of ELTP is $11.94M, an increase of 20.24% to 2022. At the end of 2022 company had $9.93M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Elite Pharmaceuticals is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $11.94M | 20.24% |
2022 | $9.93M | -1.10% |
2021 | $10.04M | -29.81% |
2020 | $14.30M | 117.82% |
2019 | $6.57M | - |